Xiao-jun Huang - JoVE Visualize

Showing results (621-630 of 1,072) with videos related to

Pageof 108

Sort By:

Acta Haematologica|November 29, 2008

Imatinib mesylate resistance in a chronic myeloid leukemia patient with a novel e8a2 BCR-ABL transcript variantYa Zhen Qin, Bin Jiang, Qian Jiang, et al.

Science Advances|September 10, 2025

CD8+HLA-DR+CD27+ T cells define a population of naturally occurring regulatory precursors in humansHuidong Guo, Bixia Wang, Zhigui Wu, et al.

Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|December 18, 2013

[Clinical characteristics and efficacy analysis for patients over 55 years of age with acute lymphoblastic leukemia]Jing Wang, Xiao-jun Huang, Bin Jiang, et al.

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 6, 2014

Association between an impaired bone marrow vascular microenvironment and prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantationYuan Kong, Yue Hu, Xiao-Hui Zhang, et al.

Chinese Medical Journal|March 3, 2011

Administration of imatinib in the first 90 days after allogeneic hematopoietic cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemiaHuan Chen, Kai-Yan Liu, Lan-Ping Xu, et al.

Journal of Natural Products|February 20, 2014

Dysideanones A-C, unusual sesquiterpene quinones from the South China Sea sponge Dysidea avaraWei-Hua Jiao, Ting-Ting Xu, Hao-Bing Yu, et al.

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 14, 2005

[Reduced intensity of BuCy conditioning regimen for transplantation in the treatment of malignant hematologic diseases]Huan Chen, Dao-pei Lu, Xiao-jun Huang, et al.

Hematological Oncology|May 9, 2022

Combination of KIT and FLT3-ITD mutation status with minimal residual disease levels guides treatment strategy for adult patients with inv(16) acute myeloid leukemia in first complete remissionJun Wang, Feng-Ting Dao, Yu Wang, et al.

Leukemia Research|September 6, 2015

ADAM28 overexpression regulated via the PI3K/Akt pathway is associated with relapse in de novo adult B-cell acute lymphoblastic leukemiaXiao-Hui Zhang, Chen-Cong Wang, Qian Jiang, et al.

Transplantation and Cellular Therapy|October 31, 2025

Prophylactic Versus Preemptive Donor Lymphocyte Infusion in Refractory/Relapsed AML Post-Allogeneic Transplant: A Retrospective Comparative StudyNing Wu, Chen-Hua Yan, Jun Kong, et al.

Pageof 108

Showing results (621-630 of 1,072) with videos related to

Sort By:

Pageof 108

Acta Haematologica|November 29, 2008

Imatinib mesylate resistance in a chronic myeloid leukemia patient with a novel e8a2 BCR-ABL transcript variantYa Zhen Qin, Bin Jiang, Qian Jiang, et al.

Science Advances|September 10, 2025

CD8+HLA-DR+CD27+ T cells define a population of naturally occurring regulatory precursors in humansHuidong Guo, Bixia Wang, Zhigui Wu, et al.

Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|December 18, 2013

[Clinical characteristics and efficacy analysis for patients over 55 years of age with acute lymphoblastic leukemia]Jing Wang, Xiao-jun Huang, Bin Jiang, et al.

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 6, 2014

Association between an impaired bone marrow vascular microenvironment and prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantationYuan Kong, Yue Hu, Xiao-Hui Zhang, et al.

Chinese Medical Journal|March 3, 2011

Administration of imatinib in the first 90 days after allogeneic hematopoietic cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemiaHuan Chen, Kai-Yan Liu, Lan-Ping Xu, et al.

Journal of Natural Products|February 20, 2014

Dysideanones A-C, unusual sesquiterpene quinones from the South China Sea sponge Dysidea avaraWei-Hua Jiao, Ting-Ting Xu, Hao-Bing Yu, et al.

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 14, 2005

[Reduced intensity of BuCy conditioning regimen for transplantation in the treatment of malignant hematologic diseases]Huan Chen, Dao-pei Lu, Xiao-jun Huang, et al.

Hematological Oncology|May 9, 2022

Combination of KIT and FLT3-ITD mutation status with minimal residual disease levels guides treatment strategy for adult patients with inv(16) acute myeloid leukemia in first complete remissionJun Wang, Feng-Ting Dao, Yu Wang, et al.

Leukemia Research|September 6, 2015

ADAM28 overexpression regulated via the PI3K/Akt pathway is associated with relapse in de novo adult B-cell acute lymphoblastic leukemiaXiao-Hui Zhang, Chen-Cong Wang, Qian Jiang, et al.

Transplantation and Cellular Therapy|October 31, 2025

Prophylactic Versus Preemptive Donor Lymphocyte Infusion in Refractory/Relapsed AML Post-Allogeneic Transplant: A Retrospective Comparative StudyNing Wu, Chen-Hua Yan, Jun Kong, et al.

Pageof 108